Market forces like competition cannot stem the urge to merge among and between payers and providers, so neither will they staunch the price hikes in premiums.
A new Doximity survey shows 94% of American physicians using AI or at least keen on it. Just as tellingly, the pace of adoption is brisk and accelerating.
Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.
The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.
The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.
An academic medical center struggling to meet CT report turnaround time benchmarks was recently able to improve its overnight efficiency by implementing a framework designed to streamline teleradiology requests.
Nonfatal adverse events after PCI are associated with an increased risk of two-year mortality. That risk is especially high, it seems, when patients are hospitalized for heart failure symptoms such as shortness of breath and edema.
Market forces like competition cannot stem the urge to merge among and between payers and providers, so neither will they staunch the price hikes in premiums.
